Bayu Ardiansah

Dr. Bayu Ardiansah


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2024 in Molecules
Verified
Journal Article
Open access
PDF file
NRNur Rohman
Nur Rohman
BABayu Ardiansah
Bayu Ardiansah
TWTuti Wukirsari
Tuti Wukirsari
Zaher JudehZaher Judeh
Zaher Judeh
Molecular hybridization represents a new approach in drug discovery in which specific chromophores are strategically combined to create novel drugs with enhanced therapeutic effects. This innovative strategy leverages the strengths of individual chromophores to address complex biological challenges, synergize beneficial properties, optimize pharmacokinetics, and overcome limitations associated with single-agent therapies. Coumarins are documented to possess several bioactivities and have therefore been targeted for combination with other active moieties to create molecular hybrids. This review summarizes recent (2013–2023) trends in the synthesis of coumarins, as well as coumarin–chalcone and coumarin–triazole molecular hybrids. To cover the wide aspects of this area, we have included differently substituted coumarins, chalcones, 1,2,3– and 1,2,4–triazoles in this review and considered the point of fusion/attachment with coumarin to show the diversity of these hybrids. The reported syntheses mainly relied on well-established chemistry without the need for strict reaction conditions and usually produced high yields. Additionally, we discussed the bioactivities of the reported compounds, including antioxidative, antimicrobial, anticancer, antidiabetic, and anti-cholinesterase activities and commented on their IC50 where possible. Promising bioactivity results have been obtained so far. It is noted that mechanistic studies are infrequently found in the published work, which was also mentioned in this review to give the reader a better understanding. This review aims to provide valuable information to enable further developments in this field.

1 December 2017 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
BABayu Ardiansah
Bayu Ardiansah
Pyrazole is a five-membered heterocyclic compound containing two nitrogen atoms. Due to its biological significance, design of novel pyrazole derivatives has become an interesting research area. We report the current progress in the development of anticancer agents containing pyrazole ring covering the time span of the past few years (2013–2016). The presence of this nucleus is accompanied with some side chains, functional groups, or in combination with other nucleus such as thiazole, thiourea, glucosamine, naphthalimide, and benzofuran. Several biologically active pyrazoles synthesized by numerous researchers across the world are summarized in this paper.

1 August 2019 in Journal of Applied Pharmaceutical Science
Verified
Journal Article
Open access
BABayu Ardiansah
Bayu Ardiansah

1 May 2023 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
BABayu Ardiansah
Bayu Ardiansah
NRNur Rohman
Nur Rohman
MNMochammad Arfin Fardiansyah Nasution
Mochammad Arfin Fardiansyah Nasution
HTHiroki Tanimoto
Hiroki Tanimoto
ACAntonius Herry Cahyana
Antonius Herry Cahyana
TATitin Ariyani
Titin Ariyani
Diabetes mellitus (DM) is a metabolic condition that is a major health concern around the world. The current study investigates the synthesis of a series of chalcone and 1H-1,2,3-triazole hybrid compounds and their in vitro inhibitory potential against α-glucosidase. The antidiabetic analysis revealed that compounds 4a and 4b are highly active agents with IC50 of 3.90 and 4.77 µM, respectively. These results are close to quercetin (IC50 = 4.24 µM) as the reference standard. Molecular docking study strongly supports the active interaction of the 4a and 4b to the enzyme through cation–π interaction and hydrogen bonding between the ligands and the active site of Saccharomyces cerevisiae α-glucosidase enzyme. This study broadened the potential of designing chalcone-triazole hybrid compounds as antidiabetic drug candidates in the pharmaceutical sector.

27 July 2023 in Case Studies in Chemical and Environmental Engineering
Verified
Journal Article
Open access
BABayu Ardiansah
Bayu Ardiansah
MHMuhammad Ridho Hardhani
Muhammad Ridho Hardhani
DPDecky Duem Syaban Ridho Putera
Decky Duem Syaban Ridho Putera
TWTuti Wukirsari
Tuti Wukirsari
ACAntonius Herry Cahyana
Antonius Herry Cahyana
MKMusawwer Khan
Musawwer Khan

7 December 2018 in Asian Journal of Pharmaceutical and Clinical Research
Verified
Journal Article
Open access
PDF file
BABayu Ardiansah
Bayu Ardiansah
Objective: In this review, we report antimicrobial candidates containing pyrazole nucleus integrated with various functionalities.Methods: research results by numerous scientists have been summarized from international journals indexed in reputed database such as Scopus and Web of Science.Results: Pyrazole derivatives are much of interest as potent bioactive molecules. They have shown large bioactivities especially antimicrobial performance against broad spectrum of bacterial strains.Conclusion: Several designed pyrazole derivates possessed good to superior antimicrobial activities.